Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2

Status

Completed 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 2

Conditions

Neoplasms 4Venous Thrombosis 2Venous Thromboembolism 2Upper Extremity Deep Vein Thrombosis 1Thrombosis 1Pulmonary Embolism 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Has results × Rivaroxaban × Clear all
NCT03506815 2024-07-05

TRIM-Line

Ottawa Hospital Research Institute

Phase 3 Completed
105 enrolled 15 charts

Neoplasms, Upper Extremity Deep Vein Thrombosis

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01999179 2022-05-18

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Medical College of Wisconsin

Phase NA Completed
27 enrolled 8 charts

Neoplasms, Venous Thrombosis

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Janssen Research & Development, LLC

Phase 3 Completed
841 enrolled 24 charts
Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡